Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Vladimir E. Kolesnikov"'
Autor:
Elena Yu Zlatnik, Inna A. Novikova, Elena S. Bondarenko, Yuriy A. Gevorkyan, Natalya V. Soldatkina, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Oksana V. Katelnitskaya, Sergei A. Ilchenko, Elena A. Dzhenkova, Oleg I. Kit, Aleksandr V. Snezhko, Evgeniy N. Kolesnikov, Aleksey Yu. Maksimov, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 40:e15501-e15501
e15501 Background: The purpose of this study was to demonstrate the importance of circulating tumor cells (CTCs) in the formation of immunosuppression in colon cancer. Methods: 200 patients with stage II-IV colon cancer underwent surgery as the first
Autor:
Elena Yu Zlatnik, Inna A. Novikova, Elena P. Ulianova, Elena S. Bondarenko, Yuriy A. Gevorkyan, Natalya V. Soldatkina, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Oksana V. Katelnitskaya, Sergei A. Ilchenko, Elena A. Dzhenkova, Aleksandr V. Snezhko, Evgeniy N. Kolesnikov, Aleksandr V. Shaposhnikov, Oleg I. Kit, Aleksey Yu. Maksimov
Publikováno v:
Journal of Clinical Oncology. 40:e15503-e15503
e15503 Background: The purpose of this study was to analyze the effect of the CD44+ and CD133+ co-expression in cancer stem cells (CSCs) on lymphocytic microenvironment of colon cancer (CC). Methods: 200 CC patients received surgery as the first stag
Autor:
Oleg I. Kit, Anton A. Pushkin, Dmitry Yu. Gvaldin, Inna A. Novikova, Natalya N. Timoshkina, Natalya V. Soldatkina, Yuriy A. Gevorkyan, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Oksana V. Katelnitskaya, Sergei A. Ilchenko, Elena A. Dzhenkova, Evgeniy N. Kolesnikov, Aleksey Yu. Maksimov, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 40:e15500-e15500
e15500 Background: The immune response plays a key role in the oncogenesis of colorectal cancer. The heterogeneity of the tumor environment determines the need for immunogenetic profiling to identify associations with the implementation of tumor-spec
Autor:
Yuriy A. Gevorkyan, Oksana V. Katelnitskaya, Oleg I. Kit, Andrey A. Maslov, Natalya V. Soldatkina, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Sergei A. Ilchenko, Vladimir S. Trifanov, Evgeniy N. Kolesnikov
Publikováno v:
Journal of Clinical Oncology. 40:e16243-e16243
e16243 Background: Surgical treatment is considered the main treatment for pancreatic cancer improving the patient survival. The most common obstacle to surgery with R0 resection is the involvement of the great vessels. Recently, venous resections ha
Autor:
Inna A. Novikova, Elena Yu Zlatnik, Dmitry Yu. Gvaldin, Anton A. Pushkin, Yuriy A. Gevorkyan, Natalya V. Soldatkina, Dmitriy S. Petrov, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Roman E. Tolmakh, Andrey V. Dashkov, Oksana V. Katelnitskaya, Sergei A. Ilchenko, Oleg Yu. Kaymakchi, Oleg I. Kit, Elena A. Dzhenkova, Evgeniy N. Kolesnikov, Aleksey Yu. Maksimov, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 40:e15502-e15502
e15502 Background: The purpose of this study was a comparative analysis of the expression of miRNAs in the tumor and circulating tumor cells (CTCs) in colon cancer (CC). Methods: Expression of seven miRNAs (hsa-let-7i-5p, hsa-miR-126-5p, hsa-miR-143-
Autor:
Oksana V. Katelnitskaya, Sergey I. Poluektov, Oleg Yu. Kaymakchi, Vladimir E. Kolesnikov, Dmitriy A. Savchenko, Andrey V. Dashkov, Aleksandr V. Snezhko, Oleg I. Kit, Elena M. Frantsiyants, Roman E. Tolmakh, Vladislav K. Pavlov, Dmitry O. Kaymakchi, Natalya V. Soldatkina, Maksim A. Vereshchak, Maksim K. Aleksandrovich, Yuriy A. Gevorkyan
Publikováno v:
Journal of Clinical Oncology. 39:e16220-e16220
e16220 Background: Patients with pancreatic cancer are at high risk for venous thrombosis. Thrombotic episodes are most often recorded at the tumor diagnosis, surgical treatment and chemotherapy courses, or the disease recurrence. This complication p
Autor:
Maria Sidorenko, Svetlana Yu. Filippova, Valeriy V. Kolesnikov, Anastasia O. Sitkovskaya, Anna S. Goncharova, Pavel Panchenko, Sofia V. Timofeeva, Irina V. Mezhevova, Evgeniy A. Gusakov, E.A. Lukbanova, Yuriy A. Sayapin, Vladimir E. Kolesnikov, Tatiana V. Shamova, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 39:e15043-e15043
e15043 Background: Tropolones are small, naturally occurring organic compounds that have anti-cancer effects in a variety of cancer cell lines. Among proposed mechanisms of tropolone derivatives anti-cancer activity are caspase activation, matrix met
Relationship between circulating tumor cells and ZEB1 expression in tumor cells in colorectal cancer
Autor:
Maksim K. Aleksandrovich, Oksana G. Shulgina, Elena Yu. Zlatnik, Elena P. Ulianova, Oleg I. Kit, Ellada A. Mirzoyan, Anastasia O. Sitkovskaya, Inna Arnoldovna Novikova, Maksim A. Vereshchak, Andrey V. Dashkov, Elena A. Dzhenkova, Natalya V. Soldatkina, Sergey I. Poluektov, Vladimir E. Kolesnikov, Vladislav K. Pavlov, Yuriy A. Gevorkyan, Aleksandr B. Sagakyants, Dmitry O. Kaymakchi, Oksana V. Katelnitskaya, Aleksandr V. Shaposhnikov
Publikováno v:
Journal of Clinical Oncology. 39:e15509-e15509
e15509 Background: Intravasation and circulation of tumor cells involves active invasion of cells with an enhanced migration potential as a result of the epithelial-mesenchymal transition (EMT). The ZEB1 protein is one of the key regulators of this p
Autor:
Sergey I. Poluektov, Elena P. Ulianova, Natalya V. Soldatkina, Oleg I. Kit, Dmitriy A. Savchenko, Andrey V. Dashkov, Vladislav K. Pavlov, Oksana V. Katelnitskaya, Ellada A. Mirzoyan, Vladimir E. Kolesnikov, Anastasia O. Sitkovskaya, Maksim A. Vereshchak, Maksim K. Aleksandrovich, Roman E. Tolmakh, Inna Arnoldovna Novikova, Elena A. Dzhenkova, Elena Yu. Zlatnik, Oksana G. Shulgina, Yuriy A. Gevorkyan, Dmitry O. Kaymakchi
Publikováno v:
Journal of Clinical Oncology. 39:3522-3522
3522 Background: Cancer stem cells (CSCs) capable of self-sustaining and multipotent differentiation are considered among the most important factors limiting treatment effectiveness. ALDH1 is a marker of colorectal cancer (CRC) CSCs; it is involved i
Autor:
Elena Yu. Zlatnik, Vladislav K. Pavlov, Oleg I. Kit, Maksim K. Aleksandrovich, Yuriy A. Gevorkyan, Ellada A. Mirzoyan, Inna Arnoldovna Novikova, Oksana V. Katelnitskaya, Dmitriy A. Savchenko, Anastasia O. Sitkovskaya, Andrey V. Dashkov, Sergey I. Poluektov, Natalya V. Soldatkina, Maksim A. Vereshchak, Roman E. Tolmakh, Dmitry O. Kaymakchi, Elena S. Bondarenko, Vladimir E. Kolesnikov
Publikováno v:
Journal of Clinical Oncology. 39:e15508-e15508
e15508 Background: The most important stages of metastatic cascade are extravasation and invasion of malignant cells and their surviving in blood. The vast majority of circulating tumor cells (CTC) is destroyed by immune cells. The role of immune sys